We also found no significant associations between IL-17A concentration and performance in any of the cognitive domains contrary to a study in patients with breast cancer who had lower IL-17A levels which were associated with better performance in the Psychomotor/Gross Motor Function and memory domain (55). This evidence concerns the gene IL17A and breast carcinoma.